Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2015

01-05-2015 | Letter to the Editor

Intensive BP Control Falls and Fractures

Author: Oscar M. P. Jolobe, MRCP

Published in: Journal of General Internal Medicine | Issue 5/2015

Login to get access

Excerpt

In the study by Margolis et al., although the adjusted rate of falls did not differ in the intensive and standard groups during the course of antihypertensive therapy,1 it is worth noting that no account was taken of whether or not there might be a difference between the two groups in the prevalence of orthostatic hypotension. Orthostatic hypotension is age-related in its prevalence, and is also associated with antihypertensive treatment and diabetes, respectively.2 Furthermore, although orthostatic blood pressure responses stabilize within 30 seconds of standing in subjects aged 50–59 years, there is an impairment of blood pressure stabilization with increasing age.3 Typical symptoms of orthostatic hypotension may be absent in subjects who have orthostatic hypotension. In a study that enrolled 205 subjects of mean age 71, 33 % of the subjects were asymptomatic despite profound falls in blood pressure during the head-up tilt table test.4 Accordingly, although the raw rate of falls was comparable in the intensively treated subjects vs, the standard treatment group,1 what we need to know is whether or not orthostatic hypotension (and its severity) might have contributed to falls in either group. …
Literature
1.
go back to reference Margolis KL, Palermo L, Vittinghoff E, et al. Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD Trial. J Gen Intern Med. 2014;29:599–606.CrossRef Margolis KL, Palermo L, Vittinghoff E, et al. Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD Trial. J Gen Intern Med. 2014;29:599–606.CrossRef
2.
go back to reference Fedowrski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortalityband coronary events in middle-aged individuals (the Malmo Preventive Project). Eur Heart J. 2010;31:85–91.CrossRef Fedowrski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortalityband coronary events in middle-aged individuals (the Malmo Preventive Project). Eur Heart J. 2010;31:85–91.CrossRef
3.
go back to reference Finucane C, O’Connell MDL, Fan CW, et al. Age-related normative changes in phasic orthostatic blood pressure I a large population study. Circulation. 2014;130:1780–9.CrossRefPubMed Finucane C, O’Connell MDL, Fan CW, et al. Age-related normative changes in phasic orthostatic blood pressure I a large population study. Circulation. 2014;130:1780–9.CrossRefPubMed
4.
go back to reference Arbogast SD, Alshekhlee A, Hussain Z, et al. Hypotension unawareness in profound orthostatic hypotension. Am J Med. 2009;122:574–80.CrossRefPubMed Arbogast SD, Alshekhlee A, Hussain Z, et al. Hypotension unawareness in profound orthostatic hypotension. Am J Med. 2009;122:574–80.CrossRefPubMed
Metadata
Title
Intensive BP Control Falls and Fractures
Author
Oscar M. P. Jolobe, MRCP
Publication date
01-05-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 5/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3190-0

Other articles of this Issue 5/2015

Journal of General Internal Medicine 5/2015 Go to the issue

Clinical Practice: Clinical Images

A Rare Manifestation of Tuberous Xanthomas

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine